What is LNAI's P/E ratio?

Lunai Bioworks Inc. (LNAI) currently trades at a P/E ratio of 4.10.

Lunai Bioworks Inc. reports a Return on Equity (ROE) of 1,342.81%.

What is LNAI's dividend yield?

Lunai Bioworks Inc. offers a dividend yield of 0.00%.

What is LNAI's Quality Score?

Our AI rates LNAI's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy LNAI?

Our AI Timing Score for LNAI is 69 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does LNAI belong to?

Lunai Bioworks Inc. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Lunai Bioworks Inc. (LNAI) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

LNAI AI Analysis Summary

Our AI summary for LNAI: Lunai Bioworks Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 4.10, ROE of 1,342.81%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 69/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

LNAI

Lunai Bioworks Inc.

US:NASDAQ STOCK Healthcare >> Biotechnology News 85

USD 2.48

-0.07 (-2.75%) Day Change

Watchlist Portfolio Compare Chart

4.10

P/E

-0.13

D/E

1,342.8%

ROE

-1,301.0%

ROA

0.00%

Div Yield

-0.62

PEG

LUNAI BIOWORKS INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.48 Price -0.07 (-2.75%) Day Change	NEWS SCORE: 85

LNAI, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	85
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.48
PBV / Sector	-1.21 / 44,105.10
Earning Per Share	-27.52

PE / Sector	4.10 / 19.37 GREAT
PEG or PE/Growth / Sector	-0.62 / 1.06
Average 1M Daily Value	1.15 M GREAT
Average 1W Daily Value	4.35 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-612,568.11 / 97.23
NPM Average (%) / Sector	-612,568.11 / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-1,300.98 / 185,260.64
ROA Average (%) / Sector	-744.00 / 36,684.64
ROA Change Average (%) / Sector	945.09 / 422,221.42 GREAT
ROE (%) / Sector	1,342.81 / 243,761.81
ROE Average (%) / Sector	373.61 / 48,758.38 GREAT
ROE Change Average (%) / Sector	-337.55 / 424,967.86
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

Registration Details

Analyze Date	2026-08-06 08:00:17
Symbol	LNAI
Name	LUNAI BIOWORKS INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	4.53 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	11.56 / 9,702.21

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2080 Century Park East, Los Angeles, CA, United States, 90067

Phone: 305 918 1980

Website: https://www.lunaibioworks.com

Sector: Healthcare >> Biotechnology

Description: Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.